TickerFacts.

Curanex Pharmaceuticals Inc (CURX): Total Liabilities

Annual figures by period end, from SEC filings.

$361.0K
As of 2025-12-31
$286.3K
As of 2026-06-30
2024-12-31: $14.6K2025-12-31: $361.0K$361.0K
2024-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$361.0Kn/m2026-03-30, Balance as of period end
2024-12-31$14.6Kn/a2026-03-30, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Curanex Pharmaceuticals Inc (CURX)2025-12-31$361.0Kn/m
Revelation Biosciences, Inc. (REVB)2025-12-31$2.72M+42.2%
NewcelX Ltd. (NCEL)2025-12-31$4.20M-52.9%
PRF Technologies Ltd. (PRFX)2025-12-31$2.71M+0.3%
MetaVia Inc. (MTVA)2025-12-31$5.79M-30.5%
Mira Pharmaceuticals, Inc. (MIRA)2025-12-31$702.1K-2.9%
Decoy Therapeutics Inc. (DCOY)2025-12-31$5.17M+241.9%
Anebulo Pharmaceuticals, Inc. (ANEB)2025-06-30$487.7K+87.2%
Lantern Pharma Inc. (LTRN)2025-12-31$4.50M+2.7%

Compare CURX, REVB, NCEL, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗